Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Standard
Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. / Henningsen, Maike; Köhler, N; Kersten, Jan Felix; Milde-Langosch, Karin; Beck, K; Höller, S; Müller, Volkmar; Witzel, Isabell; Jänicke, Fritz; Kilic, E.
in: DIS MARKERS, Jahrgang 28, Nr. 2, 2, 2010, S. 71-78.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
AU - Henningsen, Maike
AU - Köhler, N
AU - Kersten, Jan Felix
AU - Milde-Langosch, Karin
AU - Beck, K
AU - Höller, S
AU - Müller, Volkmar
AU - Witzel, Isabell
AU - Jänicke, Fritz
AU - Kilic, E
PY - 2010
Y1 - 2010
N2 - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.
AB - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.
U2 - 10.3233/DMA-2010-0685
DO - 10.3233/DMA-2010-0685
M3 - SCORING: Zeitschriftenaufsatz
VL - 28
SP - 71
EP - 78
JO - DIS MARKERS
JF - DIS MARKERS
SN - 0278-0240
IS - 2
M1 - 2
ER -